You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 9, September 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Neurogenetics
 •Neuro-ophthalmology
 •Alert me on articles by topic

Clinical and Genetic Heterogeneity in Progressive External Ophthalmoplegia Due to Mutations in Polymerase {gamma}

Massimiliano Filosto, MD; Michelangelo Mancuso, MD; Yutaka Nishigaki, MD; Jacklyn Pancrudo, BS; Yadollah Harati, MD; Clifton Gooch, MD; Ami Mankodi, MD; Lydia Bayne, MD; Eduardo Bonilla, MD; Sara Shanske, PhD; Michio Hirano, MD; Salvatore DiMauro, MD

Arch Neurol. 2003;60:1279-1284.

Background  The mendelian forms of progressive external ophthalmoplegia (PEO) associated with multiple mitochondrial DNA deletions are clinically heterogeneous disorders transmitted as dominant or recessive traits. Autosomal dominant PEO is caused by mutations in at least 3 genes: adenine nucleotide translocator-1 (ANT1), encoding the muscle-specific adenine nucleotide translocator; chromosome 10 open reading frame 2 (C10orf2), encoding Twinkle helicase; and polymerase {gamma} (POLG), encoding the {alpha} subunit of polymerase {gamma}. Mutations in POLG can also cause autosomal recessive PEO, which is often associated with multisystemic disorders.

Objective and Methods  To further investigate the frequency and genotype-phenotype correlations of mutations in the POLG gene, we used single-stranded conformational polymorphism analysis and direct sequencing to screen 30 patients with familial or sporadic PEO and multiple mitochondrial DNA deletions in muscle but without mutations in ANT1 and C10orf2.

Results  Four unrelated patients had novel POLG mutations. A woman with PEO and mental retardation had a heterozygous Gly1076Val mutation. Two patients, one with PEO, exercise intolerance, and gastrointestinal dysmotility and the other with PEO, neuropathy, deafness, and hypogonadism, both had a Pro587Leu change. The fourth patient, who was compound heterozygous for Ala889Thr and Arg579Trp mutations, had PEO, gastrointestinal dysmotility, and neuropathy. These mutations were not detected in 120 healthy control alleles.

Conclusions  Our results demonstrate that POLG mutations account for a substantial proportion of patients (13%) with PEO and multiple mitochondrial DNA deletions and cause both clinically and genetically heterogeneous disorders.


From the Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (Drs Filosto, Mancuso, Nishigaki, Gooch, Bonilla, Shanske, Hirano, and DiMauro and Ms Pancrudo); Baylor College of Medicine, Houston, Tex (Dr Harati); School of Medicine and Dentistry, University of Rochester, Rochester, NY (Dr Mankodi); and Good Samaritan Clinic, Portland, Ore (Dr Bayne).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Progressive External Ophthalmoplegia and Vision and Hearing Loss in a Patient With Mutations in POLG2 and OPA1
Ferraris et al.
Arch Neurol 2008;65:125-131.
ABSTRACT | FULL TEXT  

POLG1 Mutations Manifesting as Autosomal Recessive Axonal Charcot-Marie-Tooth Disease
Harrower et al.
Arch Neurol 2008;65:133-136.
ABSTRACT | FULL TEXT  

Modulation of the W748S mutation in DNA polymerase {gamma} by the E1143G polymorphismin mitochondrial disorders
Chan et al.
Hum Mol Genet 2006;15:3473-3483.
ABSTRACT | FULL TEXT  

Mitochondrial DNA polymerase-{gamma} and human disease
Hudson and Chinnery
Hum Mol Genet 2006;15:R244-R252.
ABSTRACT | FULL TEXT  

Phenotypic spectrum associated with mutations of the mitochondrial polymerase {gamma} gene
Horvath et al.
Brain 2006;129:1674-1684.
ABSTRACT | FULL TEXT  

Association of Novel POLG Mutations and Multiple Mitochondrial DNA Deletions With Variable Clinical Phenotypes in a Spanish Population
Gonzalez-Vioque et al.
Arch Neurol 2006;63:107-111.
ABSTRACT | FULL TEXT  

Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase {gamma} mutations
Winterthun et al.
Neurology 2005;64:1204-1208.
ABSTRACT | FULL TEXT  

A Novel Polymerase {gamma} Mutation in a Family With Ophthalmoplegia, Neuropathy, and Parkinsonism
Mancuso et al.
Arch Neurol 2004;61:1777-1779.
ABSTRACT | FULL TEXT  

POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement
Van Goethem et al.
Neurology 2004;63:1251-1257.
ABSTRACT | FULL TEXT  

POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness
Mancuso et al.
Neurology 2004;62:316-318.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.